Clinical Trial Detail

NCT ID NCT02458638
Title An Open Label Study of MPDL3280A in Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

Advanced Solid Tumor

Therapies

Atezolizumab

Age Groups: adult

No variant requirements are available.